Here are options plays involving promising small-caps Clearside Biomedical and Mustang Bio.
The market continues to set all-time highs almost daily, but woe to those who are left without a chair should its sweet tune end abruptly.
The ability to execute options plays at cheap prices is a big change from a quarter-century ago, and small investors would do well to employ them.
The potential buy trades are in Invitae Corp. and Salesforce.com.
Shares of the athletic apparel maker could give ground in the near term, but that would be a buying opportunity.
T2 Biosystems and Tyme Technologies have both perked up of late after languishing for extended periods of time.
The food distributor's shares appear undervalued and that presents investors with opportunity to profit by buying its shares or initiating option positions.
Oncology concern Exelixis and biopharma Ardelyx offer reasons to believe their shares should rise in the months ahead.
The charts of U.S. Steel, Freeport-McMoRan and DuPont suggest that the surge in their shares may have just begun.
Participants largely have ignored the risks to stocks posed by the makeup of the government and the lingering coronavirus, and that could be costly.